against CD28 or CD152

Industry

CPC
C07K16/2818

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K16/00Immunoglobulins [IGs]

Current Industry

C07K16/2818against CD28 or CD152

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Combining CD27 agonists and immune checkpoint inhibition for immune...
- Patent number 12,168,693
- Issue date Dec 17, 2024
- ADURO BIOTECH HOLDINGS, EUROPE B.V.
- Hans Van Eenennaam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vaccine in combination with an immune checkpoint inhibitor for use...
- Patent number 12,168,045
- Issue date Dec 17, 2024
- Ultimovacs ASA
- Gustav Gaudernack
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies to programmed cell death protein 1 that are PD-1 agonists
- Patent number 12,168,687
- Issue date Dec 17, 2024
- Georgiamune Inc.
- Mikayel Mkrtichyan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies and variants thereof against PD-L1
- Patent number 12,168,688
- Issue date Dec 17, 2024
- Nanjing Legend Biotech Co., Ltd.
- Shuai Yang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immune tolerant elastin-like peptide tetramer guided nanoparticles...
- Patent number 12,162,923
- Issue date Dec 10, 2024
- Univeristy of Utah Research Foundation
- Mingnan Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combined treatment with Netrin-1 interfering drug and immune checkp...
- Patent number 12,162,932
- Issue date Dec 10, 2024
- NETRIS PHARMA
- Benjamin Ducarouge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD112R compositions and methods
- Patent number 12,162,941
- Issue date Dec 10, 2024
- Surface Oncology, LLC
- Bianka Prinz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EPHA2 antibodies
- Patent number 12,162,945
- Issue date Dec 10, 2024
- Immunome, Inc.
- Alexander Scholz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cell assembly-mediated delivery of checkpoint inhibitors for cancer...
- Patent number 12,161,720
- Issue date Dec 10, 2024
- North Carolina State University
- Zhen Gu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified cell expansion and uses thereof
- Patent number 12,150,960
- Issue date Nov 26, 2024
- Innovative Cellular Therapeutics Holdings, Ltd.
- Lei Xiao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of renal cell carcinoma
- Patent number 12,152,075
- Issue date Nov 26, 2024
- Bristol-Myers Squibb Company
- Jason Samuel Simon
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
- Patent number 12,152,076
- Issue date Nov 26, 2024
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonistic PD-1, PD-L1 and LAG-3 binding proteins
- Patent number 12,152,074
- Issue date Nov 26, 2024
- CeingeBiotecnologie Avanzate Franco Salvatore Scarl
- Alfredo Nicosia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human Kynureninase enzymes and uses thereof
- Patent number 12,144,828
- Issue date Nov 19, 2024
- Board of Regents, The University of Texas System
- George Georgiou
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 12,145,927
- Issue date Nov 19, 2024
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for decreasing soluble immune receptor CD28
- Patent number 12,139,534
- Issue date Nov 12, 2024
- BIOND BIOLOGICS LTD.
- Motti Hakim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EphA3 directed CAR-T cells for treatment of tumors
- Patent number 12,139,544
- Issue date Nov 12, 2024
- Mayo Foundation for Medical Education and Research
- Cameron Durrant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified chimeric receptors and related compositions and methods
- Patent number 12,139,526
- Issue date Nov 12, 2024
- Juno Therapeutics, Inc.
- Lucas James Thompson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for upregulating immune responses using combinations of ant...
- Patent number 12,139,535
- Issue date Nov 12, 2024
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
5-thiazolecarboxamide kinase inhibitor and uses thereof
- Patent number 12,139,480
- Issue date Nov 12, 2024
- iOmx Therapeutics AG
- Peter Sennhenn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Agonistic anti TNFR2 antibody molecules
- Patent number 12,139,547
- Issue date Nov 12, 2024
- BioInvent International AB
- Björn Frendéus
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Halogenated xanthene composition and method for treating hematologi...
- Patent number 12,133,840
- Issue date Nov 5, 2024
- Provectus Pharmatech, Inc.
- Eric A. Wachter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mutant anti-CTLA-4 antibodies with improved immunotherapeutic effec...
- Patent number 12,129,299
- Issue date Oct 29, 2024
- ONCOC4, INC.
- Yang Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods, kits, agents and apparatuses for transduction
- Patent number 12,129,477
- Issue date Oct 29, 2024
- Juno Therapeutics GmbH
- Keenan Bashour
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combination of a selective histone deacetylase 3 (HDAC3) inhibitor...
- Patent number 12,128,018
- Issue date Oct 29, 2024
- KDAc Therapeutics, Inc.
- Edward Holson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for the treatment of cancer characterized...
- Patent number 12,129,284
- Issue date Oct 29, 2024
- Duke University
- Chuan-Yuan Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapies of HDAC inhibitors and PD-1 inhibitors
- Patent number 12,122,833
- Issue date Oct 22, 2024
- HUYABIO International, LLC
- Reid P. Bissonnette
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-PD-1 antibodies
- Patent number 12,122,834
- Issue date Oct 22, 2024
- Merck Sharp & Dohme LLC
- Laurence Fayadat-Dilman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoform-selective TGFB1 inhibitors and use thereof
- Patent number 12,122,823
- Issue date Oct 22, 2024
- SCHOLAR ROCK, INC.
- Abhishek Datta
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Induction and enhancement of antitumor immunity involving virus vec...
- Patent number 12,116,412
- Issue date Oct 15, 2024
- New York University
- Daniel Meruelo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
PD-1/TIM-3 BINDING PROTEINS FOR TREATMENT OF NSCLC and cHL
- Publication number 20240417472
- Publication date Dec 19, 2024
- Medimmune, LLC
- Natalia CEAICOVSCAIA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY CONJUGATES FOR THE TREATMENT OF CANCER
- Publication number 20240417477
- Publication date Dec 19, 2024
- B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY
- Moshe ELKABETS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
- Publication number 20240417471
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- John P. COGSWELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LAG-3 ANTAGONIST THERAPY FOR HEMATOLOGICAL CANCER
- Publication number 20240417473
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- Shivani SRIVASTAVA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR TREATING SOLID CANCER PATIENTS WITH CLONAL HEMATOPOIESI...
- Publication number 20240417812
- Publication date Dec 19, 2024
- Olatec Therapeutics, Inc.
- Charles A. Dinarello
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST ILT4, BISPECIFIC ANTI-ILT4/PD-L1 ANTIBODY AND US...
- Publication number 20240417459
- Publication date Dec 19, 2024
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination Treatment
- Publication number 20240415906
- Publication date Dec 19, 2024
- DUKE UNIVERSITY
- Darell D. Bigner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL I...
- Publication number 20240418716
- Publication date Dec 19, 2024
- MeMed Diagnostics Ltd.
- Eran EDEN
- G01 - MEASURING TESTING
Information Patent Application
CONDITIONALLY ACTIVATED IMMUNOCYTOKINES AND METHODS OF USE
- Publication number 20240417436
- Publication date Dec 19, 2024
- Bright Peak Therapeutics AG
- Vijaya Raghavan PATTABIRAMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LAG-3 ANTAGONIST THERAPY FOR LUNG CANCER
- Publication number 20240417465
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- Laurence David TOMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Linker Polypeptides
- Publication number 20240417437
- Publication date Dec 19, 2024
- TRUTINO BIOSCIENCES INC.
- Phillip S. Kim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ASSOCIATION OF A FAECALIBACTERIUM PRAUSNITZII STRAIN AND ANTI-PD-1,...
- Publication number 20240408150
- Publication date Dec 12, 2024
- EXELIOM BIOSCIENCES
- Harry SOKOL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SERUM HALF-LIFE EXTENDED PD-L1 BINDING POLYPEPTIDES
- Publication number 20240409638
- Publication date Dec 12, 2024
- Avacta Life Sciences Limited
- Amrik Basran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES AGAINST CANCER AND INFECTIOUS DISEASES
- Publication number 20240409608
- Publication date Dec 12, 2024
- NAVICURE BIOPHARMACEUTICALS LIMITED
- Chia-Mao WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD8 ANTIBODIES AND USES THEREOF
- Publication number 20240409637
- Publication date Dec 12, 2024
- Regeneron Pharmaceuticals, Inc.
- Jason T. Giurleo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-ILT4 AND ANTI-PD-1 BISPECIFIC CONSTRUCTS
- Publication number 20240409639
- Publication date Dec 12, 2024
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION...
- Publication number 20240409653
- Publication date Dec 12, 2024
- GENMAB A/S
- Alexander MUIK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMBINATION OF SEROTONIN RECEPTOR (5-HTR2B) ANTAGONIST AND AN...
- Publication number 20240408071
- Publication date Dec 12, 2024
- National Centre for Cell Science
- Girdhari LAL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT...
- Publication number 20240398944
- Publication date Dec 5, 2024
- SYNDAX PHARMACEUTICALS, INC.
- Robert GOODENOW
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FRAGMENT SIZE CHARACTERIZATION OF CELL-FREE DNA MUTATIONS FROM CLON...
- Publication number 20240401035
- Publication date Dec 5, 2024
- Illumina, Inc.
- Tingting Jiang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods Of Using Alternating Electric Fields And Checkpoint Inhibitors
- Publication number 20240399142
- Publication date Dec 5, 2024
- Novocure GmbH
- Uri Weinberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENHANCED DEPLETION OF TARGETED CELLS WITH CD47 BLOCKADE AND AN IMMU...
- Publication number 20240400688
- Publication date Dec 5, 2024
- The Board of Trustees of the Leland Stanford Junior University
- Peter Schnorr
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTIFUNCTIONAL ANTIBODY-LIGAND TRAPS TO COUNTERACT IMMUNE TOLERANCE
- Publication number 20240400683
- Publication date Dec 5, 2024
- The Johns Hopkins University
- Atul Bedi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS
- Publication number 20240400700
- Publication date Dec 5, 2024
- Bayer Aktiengesellschaft
- Sandra Berndt
- G01 - MEASURING TESTING
Information Patent Application
COMPOSITIONS AND METHODS OF TREATING MELANOMA
- Publication number 20240398891
- Publication date Dec 5, 2024
- University of Iowa Research Foundation
- Michael K. Schultz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD20-PD1 BINDING MOLECULES AND METHODS OF USE THEREOF
- Publication number 20240400687
- Publication date Dec 5, 2024
- Regeneron Pharmaceuticals, Inc.
- Yang SHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS TO PREDICT THE EFFICACY OF NEOADJUVANT ANTI-PD-1 THERAPY IN...
- Publication number 20240393339
- Publication date Nov 28, 2024
- The Regents of the University of California
- Roger S. Lo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATORY MOLECULES AND USES THEREOF
- Publication number 20240392004
- Publication date Nov 28, 2024
- IMMUNOWAKE INC.
- Ellen WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING CANCER
- Publication number 20240392378
- Publication date Nov 28, 2024
- FOUNDATION MEDICINE, INC.
- Garrett Michael FRAMPTON
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
FORMULATIONS OF IMMUNE CHECK POINT INHIBITORS
- Publication number 20240392006
- Publication date Nov 28, 2024
- Dr. Reddy's Laboratories Limited
- Murali JAYARAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

against CD28 or CD152

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Combining CD27 agonists and immune checkpoint inhibition for immune...

Vaccine in combination with an immune checkpoint inhibitor for use...

Antibodies to programmed cell death protein 1 that are PD-1 agonists

Antibodies and variants thereof against PD-L1

Immune tolerant elastin-like peptide tetramer guided nanoparticles...

Combined treatment with Netrin-1 interfering drug and immune checkp...

Anti-CD112R compositions and methods

EPHA2 antibodies

Cell assembly-mediated delivery of checkpoint inhibitors for cancer...

Modified cell expansion and uses thereof

Treatment of renal cell carcinoma

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

Antagonistic PD-1, PD-L1 and LAG-3 binding proteins

Human Kynureninase enzymes and uses thereof

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Methods and compositions for decreasing soluble immune receptor CD28

EphA3 directed CAR-T cells for treatment of tumors

Modified chimeric receptors and related compositions and methods

Methods for upregulating immune responses using combinations of ant...

5-thiazolecarboxamide kinase inhibitor and uses thereof

Agonistic anti TNFR2 antibody molecules

Halogenated xanthene composition and method for treating hematologi...

Mutant anti-CTLA-4 antibodies with improved immunotherapeutic effec...

Methods, kits, agents and apparatuses for transduction

Combination of a selective histone deacetylase 3 (HDAC3) inhibitor...

Compositions and methods for the treatment of cancer characterized...

Combination therapies of HDAC inhibitors and PD-1 inhibitors

Anti-PD-1 antibodies

Isoform-selective TGFB1 inhibitors and use thereof

Induction and enhancement of antitumor immunity involving virus vec...

Patents Applicationslast 30 patents

PD-1/TIM-3 BINDING PROTEINS FOR TREATMENT OF NSCLC and cHL

ANTIBODY CONJUGATES FOR THE TREATMENT OF CANCER

CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

LAG-3 ANTAGONIST THERAPY FOR HEMATOLOGICAL CANCER

METHODS FOR TREATING SOLID CANCER PATIENTS WITH CLONAL HEMATOPOIESI...

ANTIBODIES AGAINST ILT4, BISPECIFIC ANTI-ILT4/PD-L1 ANTIBODY AND US...

Combination Treatment

PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL I...

CONDITIONALLY ACTIVATED IMMUNOCYTOKINES AND METHODS OF USE

LAG-3 ANTAGONIST THERAPY FOR LUNG CANCER

Linker Polypeptides

ASSOCIATION OF A FAECALIBACTERIUM PRAUSNITZII STRAIN AND ANTI-PD-1,...

SERUM HALF-LIFE EXTENDED PD-L1 BINDING POLYPEPTIDES

COMBINATION THERAPIES AGAINST CANCER AND INFECTIOUS DISEASES

ANTI-CD8 ANTIBODIES AND USES THEREOF

ANTI-ILT4 AND ANTI-PD-1 BISPECIFIC CONSTRUCTS

MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION...

NOVEL COMBINATION OF SEROTONIN RECEPTOR (5-HTR2B) ANTAGONIST AND AN...

COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT...

FRAGMENT SIZE CHARACTERIZATION OF CELL-FREE DNA MUTATIONS FROM CLON...

Methods Of Using Alternating Electric Fields And Checkpoint Inhibitors

ENHANCED DEPLETION OF TARGETED CELLS WITH CD47 BLOCKADE AND AN IMMU...

MULTIFUNCTIONAL ANTIBODY-LIGAND TRAPS TO COUNTERACT IMMUNE TOLERANCE

CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS

COMPOSITIONS AND METHODS OF TREATING MELANOMA

CD20-PD1 BINDING MOLECULES AND METHODS OF USE THEREOF

METHODS TO PREDICT THE EFFICACY OF NEOADJUVANT ANTI-PD-1 THERAPY IN...

IMMUNOMODULATORY MOLECULES AND USES THEREOF

METHODS OF TREATING CANCER

FORMULATIONS OF IMMUNE CHECK POINT INHIBITORS